Structural multiplicity in a solvated hydrate of the antiretroviral protease inhibitor Lopinavir

Tebogo M.L. Mokoto, Andreas Lemmerer, Yasien Sayed, Mark G. Smith

Research output: Contribution to journalArticlepeer-review

Abstract

Lopinavir is a potent protease inhibitor that is used as a first-line pharmaceutical drug for the treatment of HIV. The multi-component solvated Lopinavir crystal, systematic name (2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide-ethane-1,2-diol-water (8/3/7) 8C37H48N4O5·3C2H6O2·7H2O, was prepared using evaporative methods. The crystalline material obtained from this experimental synthesis was characterized and elucidated by single-crystal X-ray diffraction (SC-XRD). The crystal structure is unusual in that the unit cell contains 18 molecules. The stoichiometric ratio of this crystal is eight Lopinavir molecules [8(C37H48N4O5)], three ethane-1,2-diol molecules [3(C2H6O2)] and seven water molecules [7(H2O)]. The crystal packing features both bi- and trifurcated hydrogen bonds between atoms.

Original languageEnglish
Pages (from-to)1206-1209
Number of pages4
JournalActa Crystallographica Section E: Crystallographic Communications
Volume80
Issue numberPt 11
DOIs
StatePublished - 1 Oct 2024
Externally publishedYes

Keywords

  • crystal structure
  • ethylene glycol
  • heterosolvate
  • hydrate
  • lopinavir
  • protease inhibitors
  • solvate

ASJC Scopus subject areas

  • General Chemistry
  • General Materials Science
  • Condensed Matter Physics

Fingerprint

Dive into the research topics of 'Structural multiplicity in a solvated hydrate of the antiretroviral protease inhibitor Lopinavir'. Together they form a unique fingerprint.

Cite this